Cargando…

White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease

White matter degeneration is a pathological hallmark of neurodegenerative diseases including Alzheimer's. Age remains the greatest risk factor for Alzheimer's and the prevalence of age-related late onset Alzheimer's is greatest in females. We investigated mechanisms underlying white m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klosinski, Lauren P., Yao, Jia, Yin, Fei, Fonteh, Alfred N., Harrington, Michael G., Christensen, Trace A., Trushina, Eugenia, Brinton, Roberta Diaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703712/ https://www.ncbi.nlm.nih.gov/pubmed/26844268 http://dx.doi.org/10.1016/j.ebiom.2015.11.002

Ejemplares similares

A ketogenic supplement improves white matter energy supply and processing speed in mild cognitive impairment
por: Roy, Maggie, et al.
Publicado: (2021)

Early Decline in Glucose Transport and Metabolism Precedes Shift to Ketogenic System in Female Aging and Alzheimer's Mouse Brain: Implication for Bioenergetic Intervention
por: Ding, Fan, et al.
Publicado: (2013)

Ovariectomy Induces a Shift in Fuel Availability and Metabolism in the Hippocampus of the Female Transgenic Model of Familial Alzheimer's
por: Ding, Fan, et al.
Publicado: (2013)

Altered brain energetics induces mitochondrial fission arrest in Alzheimer’s Disease
por: Zhang, Liang, et al.
Publicado: (2016)

Alzheimer's disease mechanisms in peripheral cells: Promises and challenges
por: Trushina, Eugenia
Publicado: (2019)

Application of Metabolomics in Alzheimer’s Disease
por: Wilkins, Jordan Maximillian, et al.
Publicado: (2018)

Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
por: Tönnies, Eric, et al.
Publicado: (2017)

Defects in Mitochondrial Dynamics and Metabolomic Signatures of Evolving Energetic Stress in Mouse Models of Familial Alzheimer's Disease
por: Trushina, Eugenia, et al.
Publicado: (2012)

Ketogenic Diet in Alzheimer’s Disease
por: Rusek, Marta, et al.
Publicado: (2019)

Lipid Metabolism in Late-Onset Alzheimer’s Disease Differs from Patients Presenting with Other Dementia Phenotypes
por: Sarrafpour, Syena, et al.
Publicado: (2019)

Sphingolipid Metabolism Correlates with Cerebrospinal Fluid Beta Amyloid Levels in Alzheimer’s Disease
por: Fonteh, Alfred N., et al.
Publicado: (2015)

Human Cerebrospinal Fluid Fatty Acid Levels Differ between Supernatant Fluid and Brain-Derived Nanoparticle Fractions, and Are Altered in Alzheimer's Disease
por: Fonteh, Alfred N., et al.
Publicado: (2014)

Mitochondrial complex I as a therapeutic target for Alzheimer's disease
por: Trushina, Eugenia, et al.
Publicado: (2022)

Accumulation of Cerebrospinal Fluid Glycerophospholipids and Sphingolipids in Cognitively Healthy Participants With Alzheimer’s Biomarkers Precedes Lipolysis in the Dementia Stage
por: Fonteh, Alfred N., et al.
Publicado: (2020)

Advances in Recapitulating Alzheimer’s Disease Phenotypes Using Human Induced Pluripotent Stem Cell-Based In Vitro Models
por: Hasan, Md Fayad, et al.
Publicado: (2022)

White Matter and Neuroprotection in Alzheimer’s Dementia
por: Lorenzini, Luca, et al.
Publicado: (2020)

Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies
por: Chew, Hannah, et al.
Publicado: (2020)

Differential effect of amyloid beta peptides on mitochondrial axonal trafficking depends on their state of aggregation and binding to the plasma membrane
por: Zhang, Liang, et al.
Publicado: (2018)

Partial Inhibition of Complex I Restores Mitochondrial Morphology and Mitochondria-ER Communication in Hippocampus of APP/PS1 Mice
por: Panes, Jessica, et al.
Publicado: (2023)

Polyunsaturated Fatty Acid Composition of Cerebrospinal Fluid Fractions Shows Their Contribution to Cognitive Resilience of a Pre-symptomatic Alzheimer’s Disease Cohort
por: Fonteh, Alfred N., et al.
Publicado: (2020)

Obesity Associated Cerebral Gray and White Matter Alterations Are Interrelated in the Female Brain
por: Mueller, Karsten, et al.
Publicado: (2014)

Structural neuroimaging in Alzheimer's disease: do white matter hyperintensities matter?
por: Brickman, Adam M., et al.
Publicado: (2009)

To treat or not to treat Alzheimer’s disease by the ketogenic diet? That is the question
por: Ułamek-Kozioł, Marzena, et al.
Publicado: (2019)

A White Matter Connection of Schizophrenia and Alzheimer’s Disease
por: Kochunov, Peter, et al.
Publicado: (2020)

White Matter Damage in Alzheimer’s Disease: Contribution of Oligodendrocytes
por: Zhou, Jinyu, et al.
Publicado: (2022)

Microvascular contributions to white matter injury in Alzheimer’s disease
por: Bagi, Zsolt, et al.
Publicado: (2023)

ABCA1‐Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease
por: Yassine, Hussein N., et al.
Publicado: (2016)

Dynamic Neuroimmune Profile during Mid-life Aging in the Female Brain and Implications for Alzheimer Risk
por: Mishra, Aarti, et al.
Publicado: (2020)

Midlife Chronological and Endocrinological Transitions in Brain Metabolism: System Biology Basis for Increased Alzheimer’s Risk in Female Brain
por: Wang, Yiwei, et al.
Publicado: (2020)

Are ketogenic diets promising for Alzheimer’s disease? A translational review
por: Lilamand, Matthieu, et al.
Publicado: (2020)

Pathophysiology of white matter perfusion in Alzheimer’s disease and vascular dementia
por: Barker, Rachel, et al.
Publicado: (2014)

The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia
por: Gordon, Brian A., et al.
Publicado: (2015)

Impact of White Matter Lesions on Depression in the Patients with Alzheimer's Disease
por: Lee, Jung Jae, et al.
Publicado: (2015)

Longitudinal changes in microstructural white matter metrics in Alzheimer's disease
por: Mayo, Chantel D., et al.
Publicado: (2016)

Effects of Homocysteine on white matter diffusion parameters in Alzheimer’s disease
por: Lee, Chen-Chang, et al.
Publicado: (2017)

White Matter Changes in Patients with Alzheimer’s Disease and Associated Factors
por: Kao, Yi-Hui, et al.
Publicado: (2019)

Increased White Matter Inflammation in Aging- and Alzheimer’s Disease Brain
por: Raj, Divya, et al.
Publicado: (2017)

Altered Superficial White Matter on Tractography MRI in Alzheimer's Disease
por: Reginold, William, et al.
Publicado: (2016)

Systems modeling of white matter microstructural abnormalities in Alzheimer's disease
por: Horgusluoglu-Moloch, Emrin, et al.
Publicado: (2020)

White matter alterations in Alzheimer’s disease without concomitant pathologies
por: Ferrer, I., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ut95bn7v47dr35hk7dbmotjrt0